Adult Oncology Clinical Trials
Breast
Lung
Gastrointestinal (GI)
Pancreatic | |
Pancreatic Cancer Screening Registry | A Registry for Pancreatic Cancer Screening in Patients with Known Genetic Mutations or Familial History |
Colon/Rectal | |
CRC- Adj Resected stage IIA rand to Tx vs. Surveillance using LUNAR assay |
Phase II/III Study of Circulating tumor DNA as a Predictive BiomaRker in Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer (COBRA) |
Genitourinary (GU)
Prostate | |
---|---|
High Risk Metastatic Hormone Sensitive Prostate | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination with Abiraterone plus Prednisone in Men with High-Risk Metastatic Hormone-Sensitive Prostate Cancer (CYCLONE 3) |
Radiation Oncology
Radiosurgery | |
---|---|
Pts. With 5-15 brain mets from any primary | Phase III Trial of Stereotactic Radiosurgery Compared with Hippocampal-Avoidant Whole Brain Radiotherapy (HA- WBRT) Plus Memantine for 5-15 Brain Metastases |
RAD ONC: Pts with First or second distant brain relapse(s) at least 8 weeks after upfront SRS and within 21 days prior to randomization |
Phase III Trial of Salvage Stereotactic Radiosurgery (SRS) or SRS + Hippocampal-Avoidant Whole Brain Radiotherapy (HA- WBRT) for First or Second Distant Brain Relapse After Upfront SRS With Brain Metastasis Velocity >= 4 Brain Metastases/Year |
RAD ONC (Lung): Pts Stage I-IIA or limited T3N0M0 (NSCLC), without radiographic evidence of nodal or distant involvement (N0M0) | A Randomized Phase III Trial of Induction/Consolidation Atezolizumab + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC |
Basket Trials
Hematology (HEME)